Nue, the revenue lifecycle platform transforming how companies manage quote-to-revenue operations, today announced Nue AI, the first context-aware AI designed to make modern revenue systems easier to ...

Rare disease drug development presents unique challenges: patient populations are often minimal, clinical endpoints may not be well-established and traditional approaches to evidence generation cannot ...

Pave Bank announces fundraising led by Accel to expand its corporate and institutional bank offering that unifies traditional ...

For long-term investors looking to ride the wave of AI-powered productivity, UiPath might just be one of the more underappreciated names worth watching closely.